Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06034314
PHASE1

Oral Dronabinol-HIV

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

The purpose of this study is to define the mechanisms of cannabis on the genome of people with HIV who use cannabis. The investigator aims to better understand the effect of Dronabinol on immune and inflammatory functions, and whether these changes are HIV-status dependent. This research may better inform public health policy regarding cannabis use. Depending on the results, additional studies may also build upon this research to develop more effective and specific treatments for cannabis use associated disorders.

Official title: Investigation of the Effects of Cannabis on the Immune-genome in People With HIV

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2023-09-21

Completion Date

2028-10-01

Last Updated

2025-11-05

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Dronabinol Capsules

Two 10 mg Dronabinol capsules will be administered orally, for a total of 20mg, on test day.

Locations (1)

Connecticut Mental Health Center

New Haven, Connecticut, United States